Cardiac Safety Services
Cambridge Bioscience represent B'SYS. As a result, we are able to offer a complete range of cardiac safety services.
B'SYS provide a comprehensive invitro proarrythmia array for full resolution of potential cardiac risk prior to IND submission.
Multiple assays are employed to assess a compound’s effect on all cardiac ion channels at molecular, cellular and system levels. CiPA testing can also be used to resolve discordances between S7B recommended assays or issues identified during the clinical trial phase.
To discuss either a full CiPA project, or any of the individual assays that comprise it, please contact us directly by email.
Material Available For Download
Detection of Cardioactive Drugs using the CardioExcyte96™